Contribution of gestational diabetes mellitus heterogeneity and prepregnancy body mass index to large-for-gestational-age infants-A retrospective case-control study
- PMID: 32935481
- DOI: 10.1111/1753-0407.13113
Contribution of gestational diabetes mellitus heterogeneity and prepregnancy body mass index to large-for-gestational-age infants-A retrospective case-control study
Abstract
Objective: To study the associations between heterogeneity of gestational diabetes mellitus (GDM) subtype/prepregnancy body mass index (pre-BMI) and large-for-gestational-age (LGA) infants of Chinese women.
Methods: We performed a retrospective case-control study of 299 women with GDM and 204 women with normal glucose tolerance (NGT), using oral glucose tolerance test-based indices performed at 24-25 weeks of gestation. Women with GDM were classified into the following three physiologic subtypes: GDM with a predominant insulin-secretion defect (GDM-dysfunction), GDM with a predominant insulin-sensitivity defect (GDM-resistance), or GDM with both defects (GDM-mixed). We then used a binary logistic regression model to evaluate the potential associations of GDM subtypes and pre-BMI with newborn macrosomia or LGA.
Results: Women with GDM-resistance had a higher pre-BMI (P < 0.001), whereas women in the GDM-dysfunction and GDM-mixed groups had pre-BMIs comparable to the NGT group. In the logistic regression model, women in the GDM-mixed group exhibited an increased risk of bearing newborns with macrosomia and LGA, and women in the GDM-dysfunction group tended to have newborns with LGA after adjusting for pre-BMI and other potential confounders. Women who were overweight or obese prepregnancy manifested an increased risk of having newborns with macrosomia and LGA relative to normal-weight women, regardless of whether values were unadjusted or adjusted for all potential confounders. There was no significant interaction between GDM subtype and pre-BMI for any of the studied outcomes.
Conclusions: Heterogeneity of GDM (GDM-dysfunction and GDM-mixed) and prepregnancy overweight/obesity were independently associated with LGA in Chinese women. There was no significant interaction between GDM subtypes and pre-BMI for LGA.
目的: 研究中国孕妇中, 妊娠期糖尿病(gestational diabetes mellitus, GDM)异质性分型及孕前体重指数分层(pre-pregnancy body mass index, pre-BMI)与大于胎龄儿(large-for-gestational-age, LGA)的关系。 方法: 我们进行了一项回顾性病例对照研究, 我们分析了299例GDM孕妇和204例正常糖耐量(normal glucose tolerance, NGT)孕妇的临床数据。诊断GDM依据妊娠第24-25周的口服糖耐量试验结果, 按照生理特征将GDM孕妇分为以下三种亚型: 以胰岛素分泌缺陷为主要特征的亚型(GDM-dysfunction, GDM-dys), 以胰岛素敏感性缺陷为主要特征的亚型(GDM-resistance, GDM-res), 或以上两种特征缺陷均具备的亚型(GDM-mixed)。使用二元logistic回归模型分析GDM亚型/pre-BMI与巨大儿或LGA的潜在关联。 结果: GDM-res组的pre-BMI较高(P < 0.001), 而GDM-dys组和GDM-mixed组与NGT组的pre-BMI相当。在logistic回归模型中, GDM-mixed组生产巨大儿和LGA的风险增加, 而校正pre-BMI和其他潜在混杂因素后, GDM-dys组生产LGA的风险也增加。与正常孕前体重的孕妇相比, 无论是否调整潜在混在因素, 孕前超重/肥胖的孕妇生产巨大儿和LGA的风险均较高。同时, 本研究未发现GDM各亚型和各pre-BMI分组之间存在显著的交互作用。 结论: 中国GDM孕妇中, 依据异质性分组, GDM-dys/GDM-mixed亚型和孕前超重/肥胖与LGA独立相关。GDM各亚型与pre-BMI各分组之间对于LGA的影响没有显著的交互作用。.
Keywords: gestational diabetes mellitus; heterogeneity; obesity; retrospective study; 回顾性研究; 妊娠期糖尿病; 异质性; 肥胖.
© 2020 Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd.
Similar articles
-
Interactive effects of prepregnancy overweight and gestational diabetes on macrosomia and large for gestational age: A population-based prospective cohort in Tianjin, China.Diabetes Res Clin Pract. 2019 Aug;154:82-89. doi: 10.1016/j.diabres.2019.06.014. Epub 2019 Jul 1. Diabetes Res Clin Pract. 2019. PMID: 31271809
-
Associations between body mass index and maternal weight gain on the delivery of LGA infants in Chinese women with gestational diabetes mellitus.J Diabetes Complications. 2015 Nov-Dec;29(8):1037-41. doi: 10.1016/j.jdiacomp.2015.08.017. Epub 2015 Aug 22. J Diabetes Complications. 2015. PMID: 26376766
-
Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus.Acta Obstet Gynecol Scand. 2010 May;89(5):700-4. doi: 10.3109/00016341003605677. Acta Obstet Gynecol Scand. 2010. PMID: 20423280
-
Update on gestational diabetes and adverse pregnancy outcomes.Curr Opin Obstet Gynecol. 2023 Oct 1;35(5):453-459. doi: 10.1097/GCO.0000000000000901. Epub 2023 Aug 9. Curr Opin Obstet Gynecol. 2023. PMID: 37560815 Review.
-
New approaches in the diagnosis and prognosis of gestational diabetes mellitus.Eur Rev Med Pharmacol Sci. 2023 Nov;27(21):10583-10594. doi: 10.26355/eurrev_202311_34338. Eur Rev Med Pharmacol Sci. 2023. PMID: 37975383 Review.
Cited by
-
Metabolomic and genetic architecture of gestational diabetes subtypes.Diabetologia. 2024 Feb 17. doi: 10.1007/s00125-024-06110-x. Online ahead of print. Diabetologia. 2024. PMID: 38367033
-
Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis.Commun Med (Lond). 2023 Dec 18;3(1):185. doi: 10.1038/s43856-023-00393-8. Commun Med (Lond). 2023. PMID: 38110524 Free PMC article.
-
Contribution of Insulin Resistance and β Cell Dysfunction to Gestational Diabetes Stratified for Pre-pregnant Body Mass Index.Reprod Sci. 2023 Nov 13. doi: 10.1007/s43032-023-01379-6. Online ahead of print. Reprod Sci. 2023. PMID: 37957467
-
Combined Effect of Maternal Obesity and Diabetes on Excessive Fetal Growth: Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 2012-2015.AJPM Focus. 2023 Feb 1;2(2):100071. doi: 10.1016/j.focus.2023.100071. eCollection 2023 Jun. AJPM Focus. 2023. PMID: 37790647 Free PMC article.
-
Development and validation of risk prediction models for large for gestational age infants using logistic regression and two machine learning algorithms.J Diabetes. 2023 Apr;15(4):338-348. doi: 10.1111/1753-0407.13375. Epub 2023 Mar 8. J Diabetes. 2023. PMID: 36890429 Free PMC article.
References
REFERENCES
-
- American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14-S31. https://doi.org/10.2337/dc20-S002.
-
- Spaight C, Gross J, Horsch A, Puder JJ. Gestational diabetes mellitus. Endocr Dev. 2016;31:163-178. https://doi.org/10.1159/000439413.
-
- Tabrizi R, Asemi Z, Lankarani KB, et al. Gestational diabetes mellitus in association with macrosomia in Iran: a meta-analysis. J Diabetes Metab Disord. 2019;18(1):41-50. https://doi.org/10.1007/s40200-019-00388-0.
-
- Huvinen E, Eriksson JG, Koivusalo SB, et al. Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up. Acta Diabetol. 2018;55(5):493-501. https://doi.org/10.1007/s00592-018-1118-y.
-
- Huvinen E, Grotenfelt NE, Eriksson JG, et al. Heterogeneity of maternal characteristics and impact on gestational diabetes (GDM) risk-implications for universal GDM screening? Ann Med. 2016;48(1-2):52-58. https://doi.org/10.3109/07853890.2015.1131328.
MeSH terms
Substances
Grants and funding
- G-X-2019-056/Bethune-Merck Diabetes Research Foundation
- XJTU1AF-CRF-2019-007/Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University, China
- 81801459/National Natural Science Foundation of China
- 2018M641001/National Science Foundation for Postdoctoral Scientists of China
- 2019JQ069/Natural Science Foundation of Shaanxi Province
LinkOut - more resources
Full Text Sources
Medical
